Patient financing is one of the most underleveraged conversion levers in cosmetic and aesthetic marketing. Practices that actively market financing options consistently see higher case acceptance rates.
Research from cosmetic practice surveys consistently shows that practices that actively present financing options at consultation see 20 to 35 percent higher case acceptance rates than those that mention financing only when patients ask. Patients who would not have paid cash for a procedure often proceed readily when monthly payment options are presented as the primary pricing frame.
On procedure pricing pages, in ad copy for higher-ticket procedures, and prominently on consultation landing pages. Mentioning affordable monthly payments alongside the total procedure cost reframes the purchase decision from one large payment to a manageable monthly commitment. This reframing consistently improves both click-through rates on ads and landing page conversion rates.
CareCredit, Alphaeon Credit, and Ally Lending are the most widely used in cosmetic and aesthetic medicine. Each has different approval rates, patient-facing products, and provider fee structures. Many practices offer two or more options to maximize approval rates for patients with varying credit profiles. The approval rate across all financing options combined is typically 70 to 85 percent of applicants.
Yes. Truth in Lending Act requirements apply to any financing marketing. Advertising a monthly payment or interest rate requires specific disclosures. Phrases like affordable monthly payments are generally acceptable. Specific monthly payment amounts with interest rates require full TILA disclosure. Any financing marketing should be reviewed for compliance before publication.